Article Details

Ersodetug Designated Orphan Drug for Hypoglycemia Due to Tumor Hyperinsulinism - MPR

Retrieved on: 2024-12-03 16:48:10

Tags for this article:

Click the tags to see associated articles and topics

Ersodetug Designated Orphan Drug for Hypoglycemia Due to Tumor Hyperinsulinism - MPR. View article details on hiswai:

Excerpt

... monitored blood glucose. Other efficacy outcome measures include overall hypoglycemia events, time in hypoglycemia by continuous glucose monitor ...

Article found on: www.empr.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up